425.Howard E.L., Becker K.C.D., Rusconi C.P., Becker R.C. Factor IXa Inhibitors as Novel Anticoagulants // Arterioscler. Thromb. Vasc. Biol. 2007. V.27. P.722-727.
426.Hsiung C., Patel D.J. // Nat. Struct. Biol. 1996. V.3. P.1046–1050.
427.Huang F., Bugg C.W., Yarus M. RNA-Catalyzed CoA, NAD, and FAD synthesis from phosphopantetheine, NMN, and FMN // Biochemistry. 2000. V.39. P.1554815555.
428.Huang F., Yang Z., Yarus M. RNA enzymes with two small-molecule substrates // Chem. Biol. 1998. V.5. P.669–678.
429.Huang F., Yarus M. 5'-RNA self-capping from guanosine diphosphate // Biochemistry. 1997. V.36. P.6557-6563.
430.Huang Z., Szostak J.W. Evolution of aptamers with a new specificity and new secondary structures from an ATP aptamer // RNA. 2003. V.9. P.1456-1463.
431.Huizenga D.E., Szostak J.W. A DNA aptamer that binds adenosine and ATP // Biochemistry. 1995. V.34. P.656–665.
432.Hwang B., Cho J.S., Yeo H.J., Kim J.H., Chung K.M., Han K., Jang S.K., Lee S.W. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus // RNA. 2004. V.10. P.1277–1290.
433.Hwang B., Lee S.W. Improvement of RNA aptamer activity against myasthenic autoantibodies by extended sequence selection // Biochem. Biophys. Res. Commun. 2002. V.290. P.656-662.
434.Hwang J., Fauzi H., Fukuda K., Sekiya S., Kakiuchi N., Shimotohno K., Taira K., Kusakabe I., Nishikawa S. The RNA aptamer-binding site of hepatitis C virus NS3 protease // Biochem. Biophys. Res. Commun. 2000. V.279. P.557–562.
435.Hwang J., Nishikawa S. Novel Approach to Analyzing RNA Aptamer-Protein Interactions: Toward Further Applications of Aptamers // J. Biomol. Screen. 2006. V.11. P.599-605.
436.Hybarger G., Bynum J., Williams R.F., Valdes J.J., Chambers J.P. A microfluidic SELEX prototype // Anal. Bioanal. Chem. 2006. V.384. P.191-198.
437.Jagannathan V., Roulet E., Delorenzi M., Bucher P. HTPSELEX--a database of high-throughput SELEX libraries for transcription factor binding sites // Nucleic Acids Res. 2006. V.34. P.D90-D94.
111
438.James W. Aptamers in the virologists' toolkit // J. Gen. Virol. 2007. V.88. P.351364.
439.Jarosch F., Buchner K., Klussmann S. In vitro selection using a dual RNA library that allows primerless selection // Nucleic Acids Res. 2006. V.34. P.e86.
440.4. Jäschke A. Artificial ribozymes and deoxyribozymes // Curr. Opin. Struct. Biol. 2001. V.11. P.321–326.
441.Jaschke A., Seelig B. Evolution of DNA and RNA as catalysts for chemical reactions // Curr. Opin. Struct. Biol. 2000. V.4. P.257–262.
442.Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics // Clin. Chem. 1999. V.45. P.1628–1650.
443.Jayasena V.K., Gold L. In vitro selection of self-cleaving RNAs with a low pH optimum // Proc. Natl. Acad. Sci. USA. 1997. V.94. P.10612-10617.
444.Jellinek D., Green L.S., Bell C., Janjic N. Inhibition of receptor-binding by highaffinity RNA ligands to vascular endothelial growth-factor // Biochemistry. 1994. V.33. P.10450–10456.
445.Jellinek D., Green L.S., Bell C., Lynott C.K., Gill N., Vargeese C., Kirschenreuter G., McGee D.P., Abesinghe P., Pieken W.A., Shapiro R., Rifkin D.B., Moscatelli D., Janjic N. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor // Biochemistry. 1995. V.34. P.11363–11372.
446.Jenison R.D., Gill S.C., Pardi A., Polisky B. High-resolution molecular discrimination by RNA // Science. 1994. V.263. P.1425–1429.
447.Jenison R.D., Jennings S.D., Walker D.W., Bargatze R.F., Parma D. Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion // Antisense Nucleic Acid Drug Dev. 1998. V.8. P.265-279.
448.Jenne A., Famulok M. A novel ribozyme with ester transferase activity // Chem. Biol. 1998. V.5. P.23-34.
449.Jensen K.B., Atkinson B.L., Willis M.C., Koch T.H., Gold L. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands // Proc. Natl. Acad. Sci. USA. 1995. V.92. P.12220-12224.
112
450.Jeon S. H., Kayhan B., Ben-Yedidia T., Arnon R. A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin // J. Biol. Chem. 2004. V.279. P.48410–48419.
451.Jeong S., Eom T., Kim S., Lee S., Yu J. In vitro selection of the RNA aptamer against the Sialyl Lewis X and its inhibition of the cell adhesion // Biochem. Biophys. Res. Commun. 2001. V.281. P.237–243.
452.Jepsen J.S., Wengel J. LNA-antisense rivals siRNA for gene silencing // Curr. Opin. Drug Discov. Devel. 2004. V.7. P.188–194.
453.Jhaveri S., Rajendran M., Ellington A.D. In vitro selection of signaling aptamers // Nat. Biotechnol. 2000. V.18. P.1293–1297.
454.Jiang F., Kumar R.A., Jones R.A., Patel D.J. Structural basis of RNA folding and recognition in an AMP–RNA aptamer complex // Nature. 1996. V.382. P.183–186.
455.Jiang F., et al. // Structure Fold. Des. 1991. V.7. P.1461.
456.Jiang L.C., Majumdar A., Hu W.D., Jaishree T.J., Xu W.K., Patel D.J. SaccharideRNA recognition in a complex formed between neomycin B and an RNA aptamer // Structure Fold. Des. 1999. V.7. P.817–827.
457.Jiang L., Patel D.J. Solution structure of the tobramycin-RNA aptamer complex // Nature Struct. Biol. 1998. V.5. P.769–774.
458.Jiang L., Suri A.K., Fiala R., Patel D.J. Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex // Chem. Biol. 1997. V.4. P.35.
459.Jiang Y., Wang J., Fang X., Bai C. Study of the effect of metal ion on the specific interaction between protein and aptamer by atomic force microscopy // J. Nanosci. Nanotechnol. 2004. V.4. P.611–615.
460.Jiang Y., Zhu C., Ling L., Wan L., Fang X., Bai C. Specific aptamer-protein interaction studied by atomic force microscopy // Anal. Chem. 2003. V.75. P.21122116.
461.Johns G.C., Joyce G.F. The promise and peril of continuous in vitro evolution // J. Mol. Evol. 2005. V.61. P.253-263.
462.Johnson S.C., Sherrill C.B., Marshall D.J., Moser M.J., Prudent J.R. A third base pair for the polymerase chain reaction: inserting isoC and isoG // Nucleic Acids Res. 2004. V.32. P.1937-1941.
113
463.Johnston W.K., Unrau P.J., Lawrence M.S., Glasner M.E., Bartel D.P. RNACatalyzed RNA Polymerization: Accurate and General RNA-Templated Primer Extension // Science. 2001. V.292. P.1319-1325.
464.Jose A.M., Soukup G.A., Breaker R.R. Cooperative binding of effectors by an allosteric ribozyme // Nucleic Acids Res. 2001. V.29. P.1631-1637.
465.Joyce G.F. Directed Evolution of Nucleic Acid Enzymes // Annu. Rev. Biochem. 2004. V.73. P.791-836.
466.12. Joyce G.F. // Curr. Opin. Struct. Biol. 1994. V.4. P.331.
467.Jucker F.M., Phillips R.M., McCallum S.A., Pardi A. Role of a heterogeneous free state in the formation of a specific RNA-theophylline complex // Biochemistry. 2003. V.42. P.2560-2567.
468.Juliano R.L., Astriab-Fisher A., Falke D. Macromolecular Therapeutics: Emerging Strategies for Drug Discovery in the Postgenome Era // Mol. Interv. 2001. V.1. P.4053.
469.Ikebukuro K., Okumura Y., Sumikura K., Karube I. A novel method of screening thrombin-inhibiting DNA aptamers using an evolution-mimicking algorithm // Nucleic Acids Res. 2005. V.33. P.e108.
470.Illangasekare M., Sanchez G., Nickles T., Yarus M. Aminoacyl-RNA synthesis catalyzed by an RNA // Science. 1995. V.267. P.643–647.
471.Illangasekare M., Yarus M. Specific, rapid synthesis of Phe-RNA by RNA // Proc. Natl. Acad. Sci. USA. 1999. V.96. P.5470-5475.
472.Illangasekare M., Yarus M. A tiny RNA that catalyzes both aminoacyl-RNA and peptidyl-RNA synthesis // RNA. 1999. V.5. P.1482-1489.
473.Ireson C.R., Kelland L.R. Discovery and development of anticancer aptamers // Mol. Cancer Ther. 2006. V.5. P.2957-2962.
474.Isaacs F.J., Dwyer D.J., Collins J.J. // Nat. Biotechnol. 2006. V.24. P.545–554.
475.Isaacs F.J., Dwyer D.J., Ding C., Pervouchine D.D., Cantor C.R., Collins J.J. Engineered riboregulators enable post-transcriptional control of gene expression // Nat. Biotechnol. 2004. V.22. P.841–847.
476.Iyo M., Kawasaki H., Taira K. Allosterically controllable maxizymes for molecular gene therapy // Curr. Opin. Mol. Ther. 2002. V.4. P.154–165.
114
477.Iyo M., Kawasaki H., Taira K. Maxizyme technology // Methods Mol. Biol. 2004. V.252. P.257–265.
478.Kang Y., Bogerd H.P., Yang J., Cullen B.R. Analysis of the RNA binding specificity of the human Tap protein, a constitutive transport element-specific nuclear RNA export factor // Virology. 1999. V.262. P.200–209.
479.Katilius E., Flores C., Woodbury N.W. Exploring the sequence space of a DNA aptamer using microarrays // Nucleic Acids Res. 2007. V.35. P.7626-7635.
480.Kato T., Takemura T., Yano K., Ikebukuro K., Karube I. In vitro selection of DNA aptamers which bind to cholic acid. Biochim // Biochim. Biophys. Acta. 2000. V.1493. P.12-18.
481.Kato T., Yano K., Ikebukuro K., Karube I. Interaction of three-way DNA junctions with steroids // Nucleic Acids Research. 2000. V.28. P.1963-1968.
482.Kato Y., Minakawa N., Komatsu Y., Kamiya H., Ogawa N., Harashima H., Matsuda A. New NTP analogs: the synthesis of 4'-thioUTP and 4'-thioCTP and their utility for SELEX // Nucleic Acids Res. 2005. V.33. P.2942-2951.
483.Kawakami J., Imanaka H., Yokota Y., Sugimoto N. In vitro selection of aptamers that act with Zn2+ // J. Inorg. Biochem. 2000. V.82. P.197-206.
484.Keiper S., Vyle J.S. Reversible photocontrol of deoxyribozyme-catalyzed RNA cleavage under multiple-turnover conditions // Angew. Chem. Int. Ed. 2006. V.45. P.3306-3309.
485.Kelly J.A., Feigon J., Yeates T.O. Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG) // J. Mol. Biol. 1996. V.256. P.417-422.
486.Kertsburg A., Soukup G.A. A versatile communication module for controlling RNA folding and catalysis // Nucleic Acids Res. 2002. V.30. P.4599-4606.
487.Khati M., Schuman M., Ibrahim J., Sattentau Q., Gordon S., James W. Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers // J. Virol. 2003. V.77. P.12692-12698.
488.Kheradpour P., Stark A., Roy S., Kellis M. Reliable prediction of regulator targets using 12 Drosophila genomes // Genome Res. 2007. V.17. P.1919-1931.
115